Skip to main content

Targeting IL-33 in chronic obstructive pulmonary disease (COPD), chronic asthma and idiopathic pulmonary fibrosis (IPF)

Project Member(s): Donovan, C.

Funding or Partner Organisation: National Health & Medical Research Council (National Health Medical Research Council)
National Health & Medical Research Council (National Health Medical Research Council)

Start year: 2019

Publications:

Donovan, C & Hansbro, PM 2020, 'IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies', ACS Pharmacology & Translational Science, vol. 3, no. 1, pp. 56-62.
View/Download from: Publisher's site

Malyla, V, Paudel, KR, Shukla, SD, Donovan, C, Wadhwa, R, Pickles, S, Chimankar, V, Sahu, P, Bielefeldt-Ohmann, H, Bebawy, M, Hansbro, PM & Dua, K 2020, 'Recent advances in experimental animal models of lung cancer', Future Medicinal Chemistry, vol. 12, no. 7, pp. 567-581.
View/Download from: Publisher's site

Starkey, MR, Plank, MW, Casolari, P, Papi, A, Pavlidis, S, Guo, Y, Cameron, GJM, Haw, TJ, Tam, A, Obiedat, M, Donovan, C, Hansbro, NG, Nguyen, DH, Nair, PM, Kim, RY, Horvat, JC, Kaiko, GE, Durum, SK, Wark, PA, Sin, DD, Caramori, G, Adcock, IM, Foster, PS & Hansbro, PM 2019, 'IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis', European Respiratory Journal, vol. 54, no. 1, pp. 1800174-1800174.
View/Download from: Publisher's site

FOR Codes: Biological Sciences, Health, Protein trafficking